Reversible cholestasis with bile duct injury following azathioprine therapy. A case report
- 1 April 1991
- journal article
- case report
- Published by Wiley in Liver International
- Vol. 11 (2) , 89-93
- https://doi.org/10.1111/j.1600-0676.1991.tb00497.x
Abstract
ABSTRACT— A 67‐year‐old patient, with primary polymyositis and without previous evidence of liver disease, developed clinical and biochemical features of severe cholestasis 3 months after initiation of azathioprine therapy. Liver biopsy showed cholestasis with both cytological and architectural alterations of interlobular bile ducts. Azathioprine withdrawal resulted after 7 weeks in the resolution of clinical and biochemical abnormalities. It is believed that this is the first reported case of reversible azathioprine‐induced cholestasis associated with histological evidence of bile duct injury.Keywords
This publication has 12 references indexed in Scilit:
- Prolonged cholestasis and disappearance of interlobular bile ducts following chlorpropamide and erythromycin ethylsuccinate. Case of drug interaction?Liver International, 2008
- Azathioprine induced hepatic veno-occlusive disease in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1989
- Azathioprine Hypersensitivity Manifesting as Acute Focal Hepatocellular NecrosisJournal of the Royal Society of Medicine, 1986
- Azathioprine and hepatic venocclusive disease in renal transplant patientsGastroenterology, 1986
- Hepatic veno‐occlusive disease in a patient with systemic lupus erythematosusArthritis & Rheumatism, 1984
- Nodular transformation (nodular “Regenerative” hyperplasia) of the liverHuman Pathology, 1981
- Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation.Gut, 1979
- Peliosis hepatis in recipients of renal transplants.Gut, 1978
- Treatment of Psoriasis with AzathioprineBMJ, 1974
- Intrahepatic Cholestasis Due to AzathioprineGastroenterology, 1969